Log In
Thursday 19th September 2019

New breast cancer test

20th October 2011

Thousands of women could be spared unnecessary chemotherapy thanks to a new £200 test developed by British scientists that predicts whether or not their breast cancer will return after surgery.

The test - developed at the Institute for Cancer Research in London and the Royal Marsden Hospital and Queen Mary, University of London - uses technology already available in almost all NHS laboratories to estimate the risk of recurrence of the most common type of the disease, called oestrogen positive (ER+) breast cancer.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019